Gaudino G - Search Results

1

MicroRNA regulation of core apoptosis pathways in cancer.

Lima RT, Busacca S, Almeida GM, Gaudino G, Fennell DA, Vasconcelos MH. Lima RT, et al. Among authors: gaudino g. Eur J Cancer. 2011 Jan;47(2):163-74. doi: 10.1016/j.ejca.2010.11.005. Epub 2010 Dec 8. Eur J Cancer. 2011. PMID: 21145728 Review.

2

BAK and NOXA are critical determinants of mitochondrial apoptosis induced by bortezomib in mesothelioma.

Busacca S, Chacko AD, Klabatsa A, Arthur K, Sheaff M, Barbone D, Mutti L, Gunasekharan VK, Gorski JJ, El-Tanani M, Broaddus VC, Gaudino G, Fennell DA. Busacca S, et al. Among authors: gaudino g. PLoS One. 2013 Jun 7;8(6):e65489. doi: 10.1371/journal.pone.0065489. Print 2013. PLoS One. 2013. PMID: 23762382 Free PMC article.

3

MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications.

Busacca S, Germano S, De Cecco L, Rinaldi M, Comoglio F, Favero F, Murer B, Mutti L, Pierotti M, Gaudino G. Busacca S, et al. Among authors: gaudino g. Am J Respir Cell Mol Biol. 2010 Mar;42(3):312-9. doi: 10.1165/rcmb.2009-0060OC. Epub 2009 Jun 5. Am J Respir Cell Mol Biol. 2010. PMID: 19502386

4

Estrogen receptor-beta affects the prognosis of human malignant mesothelioma.

Pinton G, Brunelli E, Murer B, Puntoni R, Puntoni M, Fennell DA, Gaudino G, Mutti L, Moro L. Pinton G, et al. Among authors: gaudino g. Cancer Res. 2009 Jun 1;69(11):4598-604. doi: 10.1158/0008-5472.CAN-08-4523. Cancer Res. 2009. PMID: 19487281

5

Advances in the systemic therapy of malignant pleural mesothelioma.

Fennell DA, Gaudino G, O'Byrne KJ, Mutti L, van Meerbeeck J. Fennell DA, et al. Among authors: gaudino g. Nat Clin Pract Oncol. 2008 Mar;5(3):136-47. doi: 10.1038/ncponc1039. Nat Clin Pract Oncol. 2008. PMID: 18227828 Review.

6

Preliminary data suggestive of a novel translational approach to mesothelioma treatment: imatinib mesylate with gemcitabine or pemetrexed.

Bertino P, Porta C, Barbone D, Germano S, Busacca S, Pinato S, Tassi G, Favoni R, Gaudino G, Mutti L. Bertino P, et al. Among authors: gaudino g. Thorax. 2007 Aug;62(8):690-5. doi: 10.1136/thx.2006.069872. Epub 2007 Feb 20. Thorax. 2007. PMID: 17311837 Free PMC article.

7

Malignant pleural mesothelioma: current treatments and emerging drugs.

Belli C, Fennell D, Giovannini M, Gaudino G, Mutti L. Belli C, et al. Among authors: gaudino g. Expert Opin Emerg Drugs. 2009 Sep;14(3):423-37. doi: 10.1517/14728210903074563. Expert Opin Emerg Drugs. 2009. PMID: 19552609 Review.

8

Bortezomib inhibits nuclear factor-kappaB dependent survival and has potent in vivo activity in mesothelioma.

Sartore-Bianchi A, Gasparri F, Galvani A, Nici L, Darnowski JW, Barbone D, Fennell DA, Gaudino G, Porta C, Mutti L. Sartore-Bianchi A, et al. Among authors: gaudino g. Clin Cancer Res. 2007 Oct 1;13(19):5942-51. doi: 10.1158/1078-0432.CCR-07-0536. Clin Cancer Res. 2007. PMID: 17908991 Free article.

9

Targeting alpha7-nicotinic receptor for the treatment of pleural mesothelioma.

Catassi A, Paleari L, Servent D, Sessa F, Dominioni L, Ognio E, Cilli M, Vacca P, Mingari M, Gaudino G, Bertino P, Paolucci M, Calcaterra A, Cesario A, Granone P, Costa R, Ciarlo M, Alama A, Russo P. Catassi A, et al. Among authors: gaudino g. Eur J Cancer. 2008 Oct;44(15):2296-311. doi: 10.1016/j.ejca.2008.06.045. Epub 2008 Aug 20. Eur J Cancer. 2008. PMID: 18722110

10

Mammalian target of rapamycin contributes to the acquired apoptotic resistance of human mesothelioma multicellular spheroids.

Barbone D, Yang TM, Morgan JR, Gaudino G, Broaddus VC. Barbone D, et al. Among authors: gaudino g. J Biol Chem. 2008 May 9;283(19):13021-30. doi: 10.1074/jbc.M709698200. Epub 2008 Mar 13. J Biol Chem. 2008. PMID: 18339627 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

130 results

Search Page